Jul 29, 2026 08:00AM
May 27, 2026 07:00AM
May 7, 2026 08:00AM
Apr 13, 2026 07:31AM
Apr 13, 2026 07:30AM
Apr 7, 2026 07:00AM
Apr 7, 2026 07:00AM MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
Apr 2, 2026 03:26PM
Mar 5, 2026 04:30PM
Mar 5, 2026 07:00AM
Feb 19, 2026 08:00AM
Feb 17, 2026 08:00AM
Jan 12, 2026 07:00AM
Dec 10, 2025 07:01AM MediWound reports clinical data on NexoBrid for traumatic tattoos
Dec 10, 2025 07:00AM
Dec 10, 2025 07:00AM
Nov 20, 2025 07:00AM
Nov 5, 2025 07:30AM
Nov 5, 2025 07:30AM
Nov 3, 2025 08:00AM
Sep 29, 2025 08:38AM MediWound raises $30 million in registered direct offering
Sep 29, 2025 08:37AM
Sep 25, 2025 07:30AM
Sep 25, 2025 07:30AM
Sep 25, 2025 07:30AM
Sep 2, 2025 07:30AM
Aug 20, 2025 07:30AM
Aug 14, 2025 07:00AM MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Aug 13, 2025 08:45AM
Aug 13, 2025 08:45AM
Aug 4, 2025 07:30AM
May 21, 2025 07:00AM
May 13, 2025 07:30AM
May 13, 2025 07:30AM
May 5, 2025 08:00AM MediWound to Report First Quarter 2025 Financial Results
Apr 28, 2025 08:00AM
Mar 19, 2025 07:00AM
Mar 3, 2025 08:00AM
Feb 25, 2025 08:02AM
Feb 25, 2025 08:00AM
Feb 24, 2025 08:00AM
Feb 12, 2025 07:02AM MediWound (MDWD) Initiates the VALUE Global Phase III Trial of EscharEx
Feb 12, 2025 07:00AM
Feb 4, 2025 08:00AM
Dec 17, 2024 08:00AM
Nov 26, 2024 07:00AM
Nov 12, 2024 08:00AM
Oct 11, 2024 06:38AM
Oct 10, 2024 07:01AM MediWound (MDWD) Announces Phase II Head-to-Head Study of EscharEx vs. Collagenase in Patients with Venous Leg Ulcers
Oct 10, 2024 07:00AM

328,094 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All